|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
4/2005
vol. 4 abstract:
The case of using antiangiogenic agent – plasmide vector psFLT and radiochemotherapy in locally advanced vulvar cancer
Grzegorz Panek
,
Krzysztof Gawrychowski
,
Mariusz Bidziński
,
Ryszard Krynicki
,
Maciej Małecki
Prz Menopauz 2005; 4: 17–21
Online publish date: 2005/08/31
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
This is a case report documenting a successful use of antiangiogenic agent- plasmide vector psFLT with successive chemo-radiotherapy and radical surgery in patient with primarily unoperable invasive carcinoma of the vulva.
After 3 courses of subcutaneous injection of 30 micrograms of Plasmide vector psFLTa significant reduction of the tumor size was obtained. Subsequently chemo-irradiation was 5-Fluorouracil and Mitomycin-C was carried out resulting in complete clinical regression of the tumor. Radical vulvectomy and inguino-femoral limphadenectomy was performed 6 weeks after completion of chemo-irradiation. Microscopic examination of the specimen revealed a complete eradication of the malignant tissue. The case demonstrates a significant potential of antiangiogenic therapy combiened with chemo-irradiation for locally advanced carcinoma of the vulva. This experimental method of treatment deserves further investigation. keywords:
vulvar cancer, angiogenesis inhibitors, chemo-irradiation |
 |
